Christopher C Thompson
Overview
Explore the profile of Christopher C Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
379
Citations
5290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walradt T, Szvarca D, Hart J, Adamkiewicz G, Nie Q, Wissoker M, et al.
Am J Gastroenterol
. 2025 Feb;
PMID: 40019170
Introduction: To characterize the smoke generated during several endoscopic procedures and evaluate the efficacy of a smoke evacuation system as a preventative measure. Methods: Monitoring devices in closure proximity to...
2.
Mega P, de Moura E, Bestetti A, Ramai D, Kumar A, Hajjar L, et al.
Endoscopy
. 2025 Feb;
PMID: 39983768
Background And Study Aims: Endoscopic Vacuum Therapy (EVT) is a well-established method for managing gastrointestinal perforations. During the COVID epidemic, case reports demonstrated the effective use of EVT in controlling...
3.
4.
Jirapinyo P, Siranart N, Thompson C
Obesity (Silver Spring)
. 2025 Jan;
33(2):250-256.
PMID: 39763285
Objective: Increased use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has raised safety concerns during endoscopy due to their mechanism of delaying gastric emptying. This study aims to evaluate the impact...
5.
Jirapinyo P, Jaroenlapnopparat A, Thompson C
Endosc Int Open
. 2024 Dec;
12(12):E1458-E1464.
PMID: 39691741
Endoscopic gastric remodeling (EGR) and anti-obesity medications (AOMs) are effective weight loss therapies. While the efficacy of EGR and AOMs has been established, the effect of combination therapy and its...
6.
Pasam R, Mathews T, Schuster K, Szvarca D, Walradt T, Jirapinyo P, et al.
Gastrointest Endosc
. 2024 Nov;
101(3):580-588.e1.
PMID: 39491733
Background And Aims: EUS-guided gastroenterostomy (EUS-GE) has emerged as an alternative to surgical gastrojejunostomy and endoluminal stenting for malignant gastric outlet obstruction (MGOO). Studies regarding factors associated with the EUS-GE...
7.
Wang T, Jirapinyo P, Shah R, Schuster K, Papke D, Thompson C, et al.
Gastrointest Endosc
. 2024 Oct;
101(2):456-462.e1.
PMID: 39481576
Background And Aims: Liver fibrosis staging is challenging in patients with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Liver biopsies are invasive, whereas noninvasive tests such as vibration-controlled transient...
8.
Alkabbani W, Suissa K, Gu K, Cromer S, Paik J, Bykov K, et al.
BMJ
. 2024 Oct;
387:e080340.
PMID: 39438043
Objective: To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with...
9.
Walradt T, Thompson C
Gastrointest Endosc Clin N Am
. 2024 Sep;
34(4):671-685.
PMID: 39277298
Endoscopic sleeve gastroplasty (ESG) has emerged as a safe and effective treatment for obesity over the past decade. This procedure, however, is technically challenging and requires frequent troubleshooting, even among...
10.
Eiswerth M, Mathur P, Rashed H, Greenway F, Ravussin E, Johnson W, et al.
Obes Surg
. 2024 Jul;
34(9):3147-3160.
PMID: 39046627
Purpose: Changes in autonomic (ANS) and enteric nervous systems (ENS) may be involved in pathogenesis of obesity. We hypothesized that baseline autonomic and enteric parameters may predict outcomes of diverse...